Recombinant TFPI (Befovacimab Biosimilar) antibody
This Humanized Chimeric antibody specifically detects TFPI (Befovacimab Biosimilar) . It exhibits reactivity toward Human.
Catalog No. ABIN7597542
-15% Promotion 2026
$340.97
save $60.17 (-15 %)
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 14 Business Days
Quick Overview for Recombinant TFPI (Befovacimab Biosimilar) antibody (ABIN7597542)
Target
TFPI (Befovacimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This TFPI (Befovacimab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Befovacimab Biosimilar Antibody
-
Specificity
- Extrinsic pathway inhibitor, Lipoprotein-associated coagulation inhibitor, TFPI, EPI, LACI, TFPI1, Tissue factor pathway inhibitor
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG2 lambda
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- TFPI (Befovacimab Biosimilar)
-
Alternative Name
- Befovacimab Biosimilar
-
Target Type
- Biosimilar
-
Background
- Extrinsic pathway inhibitor, Lipoprotein-associated coagulation inhibitor, TFPI, EPI, LACI, TFPI1, Tissue factor pathway inhibitor
-
UniProt
- P10646
Target
-
You are here:
